Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$747,273
-$89,272 QoQ
Shares Held
12,969
-6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,318
of 2,506 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arvest Bank Trust Division holds $45,815,739 across 8 Drug Manufacturers - General names. BMY ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
60,049 | $15,110,729 | |
| 2 | JNJ |
Johnson & Johnson
|
57,057 | $14,490,765 | |
| 3 | LLY |
ELI LILLY & Co
|
9,403 | $11,278,240 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,386 | $1,848,601 | |
| 5 | PFE |
Pfizer Inc
|
48,596 | $1,170,191 | |
| 6 | NVS |
Novartis AG
|
5,844 | $915,871 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
12,969 | $747,273 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,011 | $254,069 |
All Filings in BMY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $747,273 | 12,969 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $836,545 | 13,793 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $704,078 | 13,053 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $549,227 | 12,178 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $526,502 | 11,374 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,999,069 | 32,777 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,835,541 | 32,453 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,723,976 | 33,320 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $854,414 | 14,440 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $686,308 | 10,271 | Shares | Sole | 2021-08-19 | |
| No filing history on record for this holder in this stock. | ||||||